3 results

Suitability of new drugs registered in Brazil from 2003 to 2013 for pediatric age groups

Jaqueline Cristina da Silveira Xavier e Castro ORCID logo , Stephanie Ferreira Botelho ORCID logo , Taisa Roberta Lopes Machado ORCID logo , Maria Auxiliadora Parreiras Martins ORCID logo , Liliana Batista Vieira ORCID logo , Adriano Max Moreira Reis ORCID logo

DOI: 10.31744/einstein_journal/2018AO4354

ABSTRACT Objective To analyze suitability of new drugs registered in Brazil from 2003 to 2013 for pediatric age groups. Methods A descriptive study of drugs with pediatric indication included in a retrospective cohort of new drugs registered in Brazil. The evaluation of drug suitability for the pediatric age group was performed using the following criteria: suitability of dosage form and capacity to deliver the recommended dose. The drugs were considered adequate for the pediatric age groups when they met both […]

Knowledge, perceptions and use of generic drugs: a cross sectional study

Claudio Andre Barbosa de Lira, Jéssica Nathalia Soares Oliveira, Marília dos Santos Andrade, Cássia Regina Vancini-Campanharo, Rodrigo Luiz Vancini

DOI: 10.1590/s1679-45082014ao3125

Objective To assess the level of knowledge, perceptions and usage profile for generic drugs among laypersons.Methods A cross-sectional study was conducted with 278 volunteers (180 women and 98 men, aged 37.1±15.8 years). A questionnaire was drawn up with questions on their use, perceptions and knowledge of generic drugs.Results Most respondents (99.6%) knew that generic drugs exist, but only 48.6% were able to define them correctly, while 78.8% of the respondents had some information about generics. This information was obtained mainly […]

Financial incentives for generic drugs: case study on a reimbursement program

Marcos Inocencio, Maria Cristina Sanches Amorim, Arnoldo Jose de Hoyos Guevara, Bruna de Vivo

DOI: 10.1590/s1679-45082010ao1478

ABSTRACTObjective:To discuss the use of financial incentives in choice of medication and to assess the economic results concerning the use of financial incentives to promote the use of genetic medication in lieu of reference drugs in a company with a reimbursement program.Methods:A case study was carried out in a large supermarket. The data was obtained in the company responsible for managing medication. The study reached 83,625 users between August 2005 and July 2007. The data was submitted to regressions in […]